Literature DB >> 30027512

Authors' Reply to Standing et al.: "Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials".

Sven C van Dijkman1, Nico C B de Jager1, Willem M Rauwé1, Meindert Danhof1, Oscar Della Pasqua2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30027512     DOI： 10.1007/s40262-018-0698-6

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  18 in total

1.  The impact of age on lamotrigine and oxcarbazepine kinetics: a historical cohort study.

Authors:  Ilse Wegner; Abraham J Wilhelm; Josemir W Sander; Dick Lindhout
Journal:  Epilepsy Behav       Date:  2013-08-29       Impact factor: 2.937

2.  Comment on "Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials".

Authors:  Joseph F Standing; Brian J Anderson; Stefanie Hennig; Nick H Holford; Trevor N Johnston; Catherijne A J Knibbe; Dagan O Lonsdale; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2018-11       Impact factor: 6.447

3.  Drug interactions between lamotrigine and psychoactive drugs: evidence from a therapeutic drug monitoring service.

Authors:  Arne Reimers; Eirik Skogvoll; Janne Kutschera Sund; Olav Spigset
Journal:  J Clin Psychopharmacol       Date:  2005-08       Impact factor: 3.153

Review 4.  Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children.

Authors:  R N Hines
Journal:  Int J Pharm       Date:  2012-07-03       Impact factor: 5.875

5.  Frequencies of UGT1A4*2 (P24T) and *3 (L48V) and their effects on serum concentrations of lamotrigine.

Authors:  Arne Reimers; Wenche Sjursen; Grethe Helde; Eylert Brodtkorb
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-12-10       Impact factor: 2.441

6.  Population pharmacokinetics of lamotrigine in elderly patients.

Authors:  Baralee Punyawudho; R Eugene Ramsay; Flavia M Macias; A James Rowan; Joseph F Collins; Richard C Brundage; Angela K Birnbaum
Journal:  J Clin Pharmacol       Date:  2008-02-22       Impact factor: 3.126

7.  Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters.

Authors:  Daniela Milosheska; Bogdan Lorber; Tomaž Vovk; Matej Kastelic; Vita Dolžan; Iztok Grabnar
Journal:  Br J Clin Pharmacol       Date:  2016-05-29       Impact factor: 4.335

8.  Efficacy, tolerability, and kinetics of lamotrigine in infants.

Authors:  Mohamad A Mikati; Michel Fayad; Majed Koleilat; Nabil Mounla; Rania Hussein; Alia Kazma; Khalid Yunis
Journal:  J Pediatr       Date:  2002-07       Impact factor: 4.406

Review 9.  The ontogeny of drug metabolism enzymes and implications for adverse drug events.

Authors:  Ronald N Hines
Journal:  Pharmacol Ther       Date:  2008-03-05       Impact factor: 12.310

10.  Population pharmacokinetics of lamotrigine in Chinese children with epilepsy.

Authors:  Da-ke He; Li Wang; Jiong Qin; Shen Zhang; Wei Lu; Ling Li; Jian-ming Zhang; Wei-qun Bao; Xiao-qing Song; Hai-tao Liu
Journal:  Acta Pharmacol Sin       Date:  2012-10-29       Impact factor: 6.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.